Risk Factors Associated With Pertussis Among Infants Less Than One-year of Age
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2015
Price : $35 *
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 28 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Jul 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jul 2013 New trial record